{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:11:18Z","timestamp":1790871078779,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1080\/14653240802072747","type":"journal-article","created":{"date-parts":[[2008,5,12]],"date-time":"2008-05-12T13:55:55Z","timestamp":1210600555000},"page":"497-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Insufficient ex vivo expansion of V\u03b124+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells"],"prefix":"10.1016","volume":"10","author":[{"given":"O.","family":"Imataki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Heike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Makiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ikarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wakasugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Takaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/14653240802072747_bib0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.15.1.535","article-title":"Mouse CD1-specific NK1 T cells: development, specificity, and function","volume":"15","author":"Bendelac","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1080\/14653240802072747_bib0010","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1084\/jem.188.8.1521","article-title":"CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution","volume":"188","author":"Brossay","year":"1998","journal-title":"J Exp Med"},{"key":"10.1080\/14653240802072747_bib0015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI200423594","article-title":"Going both ways: immune regulation via CD1d-dependent NKT cells","volume":"114","author":"Godfrey","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1080\/14653240802072747_bib0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.191.4.661","article-title":"Differential tumor surveillance by natural killer (NK) and NKT cells","volume":"191","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"10.1080\/14653240802072747_bib0025","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.188.8.1529","article-title":"CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells","volume":"188","author":"Spada","year":"1998","journal-title":"J Exp Med"},{"key":"10.1080\/14653240802072747_bib0030","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1080\/14653240802072747_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.186.1.109","article-title":"Requirements for CD1d recognition by human invariant Valpha24+ CD4\u2212 CD8\u2212 T cells","volume":"186","author":"Exley","year":"1997","journal-title":"J Exp Med"},{"key":"10.1080\/14653240802072747_bib0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.immunol.22.012703.104608","article-title":"CD1: antigen presentation and T cell function","volume":"22","author":"Brigl","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1080\/14653240802072747_bib0045","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.4049\/jimmunol.172.10.6115","article-title":"CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells","volume":"172","author":"Maeda","year":"2004","journal-title":"J Immunol"},{"key":"10.1080\/14653240802072747_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/IR:30:2:139","article-title":"Regulation of immune responses by CD1d-restricted natural killer T cells","volume":"30","author":"Van Kaer","year":"2004","journal-title":"Immunol Res"},{"key":"10.1080\/14653240802072747_bib0055","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.163.5.2387","article-title":"Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide","volume":"163","author":"Toura","year":"1999","journal-title":"J Immunol"},{"key":"10.1080\/14653240802072747_bib0060","first-page":"5102","article-title":"Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells","volume":"59","author":"Kawano","year":"1999","journal-title":"Cancer Res"},{"key":"10.1080\/14653240802072747_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2003-04-1155","article-title":"Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity","volume":"103","author":"Nieda","year":"2004","journal-title":"Blood"},{"key":"10.1080\/14653240802072747_bib0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0198-8859(98)00100-1","article-title":"Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner","volume":"60","author":"Nieda","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1080\/14653240802072747_bib0075","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.164.9.4458","article-title":"Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells","volume":"164","author":"Takahashi","year":"2000","journal-title":"J Immunol"},{"key":"10.1080\/14653240802072747_bib0080","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.167.7.4046","article-title":"Loss of IFN-gamma production by invariant NK T cells in advanced cancer","volume":"167","author":"Tahir","year":"2001","journal-title":"J Immunol"},{"key":"10.1080\/14653240802072747_bib0085","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.4049\/jimmunol.168.12.6494","article-title":"Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide","volume":"168","author":"Yanagisawa","year":"2002","journal-title":"J Immunol"},{"key":"10.1080\/14653240802072747_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1349-7006.2003.tb01451.x","article-title":"Increased expansion of V alpha 24+ T cells derived from G-CSF-mobilized peripheral blood stem cells as compared to peripheral blood mononuclear cells following alpha-galactosylceramide stimulation","volume":"94","author":"Asada-Mikami","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1080\/14653240802072747_bib0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.cji.0000163593.66910.ad","article-title":"Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials","volume":"28","author":"Harada","year":"2005","journal-title":"J Immunother"},{"key":"10.1080\/14653240802072747_bib0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.cji.0000199197.35964.8a","article-title":"Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells","volume":"29","author":"Imataki","year":"2006","journal-title":"J Immunother"},{"key":"10.1080\/14653240802072747_bib0105","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.bjc.6602218","article-title":"Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies","volume":"91","author":"Crough","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1080\/14653240802072747_bib0110","first-page":"1386","article-title":"Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1","volume":"52","author":"Hoover","year":"1992","journal-title":"Cancer Res"},{"key":"10.1080\/14653240802072747_bib0115","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.4049\/jimmunol.171.8.4105","article-title":"Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells","volume":"171","author":"Xu","year":"2003","journal-title":"J Immunol"},{"key":"10.1080\/14653240802072747_bib0120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.146.3.1077","article-title":"Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state","volume":"146","author":"Tada","year":"1991","journal-title":"J Immunol"},{"key":"10.1080\/14653240802072747_bib0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0167-5699(97)01115-8","article-title":"The host-tumor immune conflict: from immunosuppression to resistance and destruction","volume":"18","author":"Chouaib","year":"1997","journal-title":"Immunol Today"},{"key":"10.1080\/14653240802072747_bib0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s002620050620","article-title":"Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients","volume":"48","author":"Goto","year":"1999","journal-title":"Cancer Immunol Immunother"},{"key":"10.1080\/14653240802072747_bib0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002620050586","article-title":"Tumor-induced immune dysfunction","volume":"48","author":"Kiessling","year":"1999","journal-title":"Cancer Immunol Immunother"},{"key":"10.1080\/14653240802072747_bib0140","first-page":"4101","article-title":"Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells","volume":"63","author":"van der Vliet","year":"2003","journal-title":"Cancer Res"},{"key":"10.1080\/14653240802072747_bib0145","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.4049\/jimmunol.175.5.3092","article-title":"NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge","volume":"175","author":"Uldrich","year":"2005","journal-title":"J Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324908702032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324908702032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:11:53Z","timestamp":1761430313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324908702032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1465324908702032"],"URL":"https:\/\/doi.org\/10.1080\/14653240802072747","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insufficient ex vivo expansion of V\u03b124+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240802072747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}